Xometry, Inc. Class A Common Stock
XMTR
$97.18
+2.02%
Xometry, Inc. operates an AI-enabled digital marketplace that connects buyers—engineers, product designers, procurement and supply chain personnel, inventors, and business owners—with a global network of manufacturers capable of delivering CNC machining, injection molding, urethane casting, 3D printing, and die casting, primarily serving the industrial machinery sector. The company's distinguishing characteristic is its two-sided platform model, which uses machine learning to instantaneously price and route custom manufacturing orders, positioning it as a digital disruptor to traditional job shops rather than a conventional capital-intensive manufacturer. The current investor narrative centers on whether Xometry can translate rapid top-line expansion into durable profitability, with the stock having staged a dramatic recovery over the past year as gross margin gains and operating leverage have begun to materialize. At the same time, the company remains unprofitable on a GAAP basis with a negative net margin, keeping the debate squarely focused on the pace of margin expansion, the sustainability of marketplace growth, and whether the AI-driven supplier network can defend its take rate against competition.…
XMTR
Xometry, Inc. Class A Common Stock
$97.18
Investment Opinion: Should I buy XMTR Today?
Based on the synthesis of analyst consensus, valuation, and momentum, XMTR warrants a Hold rating. The core thesis is that Xometry's AI-enabled marketplace is a genuine disruptor with a 39.14% gross margin and a clear path to profitability, but the current valuation of 4.40x sales and 75.47x forward earnings already reflects much of the optimism. The analyst consensus buy rating and average target of $110.30 imply only 13.5% upside, suggesting the stock is approaching fair value after its massive run.
Supporting evidence includes the 147.91% six-month price gain, which demonstrates strong market confidence, and the 39.14% gross margin, which validates the platform's economics. The company's current ratio of 3.76 provides a solid liquidity buffer, and the narrow net loss of -$0.02 per share indicates operating leverage is emerging. However, the negative ROE of -22.41% and minimal cash generation (price-to-cash-flow of 496.5x) highlight that the profitability inflection is still ahead. The forward PE of 75.47x is high, but if the company hits the high end of EPS estimates ($3.02), the multiple would compress to a more reasonable 32x.
The biggest risks that could invalidate the thesis are a delay in reaching profitability, competitive pressure on take rates, and multiple compression due to rising interest rates. The rating would upgrade to Buy if the PS ratio compresses below 3.5x or if the company demonstrates positive free cash flow for two consecutive quarters. It would downgrade to Sell if revenue growth decelerates below 15% or if gross margins fall below 35%. Relative to its own history and the industrial machinery sector, XMTR appears overvalued on a sales basis, but fairly valued on a forward earnings basis if growth targets are met. Investors should demand a margin of safety before adding to positions.
Sign up to view all
XMTR 12-Month Price Forecast
Xometry presents a balanced risk/reward profile: the company is a high-growth disruptor with a proven marketplace model, but its premium valuation and lack of profitability leave little room for error. The analyst consensus buy rating and 13.5% upside to the average target suggest the stock is fairly valued after its 147.91% six-month run. The key to the next 12 months is whether the company can deliver on the expected earnings inflection; if it does, the stock could reach $120+, but if it stumbles, a decline to the $70s is plausible. I would upgrade to bullish if gross margins exceed 40% and free cash flow turns positive, and downgrade to bearish if revenue growth falls below 10% or if the PS multiple compresses below 3x without a corresponding improvement in fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Xometry, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $111.18 and implied upside of +14.4% versus the current price.
Average Target
$111.18
0 analysts
Implied Upside
+14.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$95 - $126
Analyst target range
Xometry is covered by 10 analysts, and the consensus recommendation is "buy" with a recommendation mean of 1.73 (on a scale where 1 is Strong Buy and 5 is Strong Sell), indicating a moderately bullish institutional stance. The average price target of $110.30 implies approximately 13.5% upside from the current price of $97.18, a modest but positive expected return that suggests the stock is approaching fair value after its massive run. The consensus leans bullish, but the relatively small implied upside—combined with the stock trading at 87.7% of its 52-week range—indicates that much of the near-term good news may already be discounted, and the buy rating is more a statement about the company's multi-year trajectory than an immediate upside call. The target range spans from a low of $95.00 to a high of $126.00, a spread of $31.00, or roughly 33% of the average target, which signals meaningful dispersion in analyst views and therefore elevated uncertainty. The high target of $126.00 implies roughly 29.7% upside and likely assumes successful margin expansion toward sustainable profitability, continued marketplace growth, and possible multiple expansion as the company proves its operating leverage; the low target of $95.00 sits just below the current price and implies about -2.2% downside, suggesting the most cautious analysts price in slower growth, competitive pressure on take rates, or delayed profitability. Notably, the low target being essentially at the current price means even the bear case does not envision a severe decline, which is a constructive signal about the downside floor. However, the absence of institutional ratings history and recent upgrade/downgrade data limits the ability to gauge whether analyst sentiment is improving or deteriorating; the wide target spread, combined with a short ratio of 6.37 days and a beta of 1.32, suggests the stock will remain volatile and that position sizing should reflect the genuine disagreement among analysts about the pace of the profitability inflection.
Drowning in data?
Find the real signal!
Bulls vs Bears: XMTR Investment Factors
The bull case rests on Xometry's explosive momentum, proven gross margins, and analyst consensus buy rating, while the bear case centers on its premium valuation, lack of profitability, and extreme volatility. Currently, the bull evidence is stronger given the 147.91% six-month gain, 39.14% gross margin, and 13.5% analyst upside, but the margin of safety is thin. The single most important tension is whether the company can deliver the expected earnings inflection (consensus EPS of $1.96) to justify a 75.47x forward PE. If profitability arrives on schedule, the stock could re-rate higher; if it stalls, the premium multiple could compress sharply.
Bullish
- Explosive Price Momentum: XMTR has surged 147.91% over six months and 85.35% over one year, massively outperforming SPY's 17.44% and 15.01% respective returns. This relative strength of 130.47 percentage points over six months signals intense market conviction in the AI-driven marketplace model.
- Gross Margin Proves Platform Economics: A 39.14% gross margin demonstrates that Xometry captures meaningful economics on transactions routed through its supplier network, validating the asset-light marketplace model. This margin level is well above traditional contract manufacturers and supports the thesis that the company can scale profitably.
- Analyst Consensus Buy with Upside: All 10 covering analysts rate the stock a buy (mean 1.73), with an average target of $110.30 implying 13.5% upside from $97.18. The high target of $126 suggests 29.7% upside if margin expansion accelerates.
- Strong Balance Sheet Liquidity: A current ratio of 3.76 provides ample short-term liquidity to fund growth without immediate financing pressure. Despite debt-to-equity of 1.27, the cash position and improving cash generation reduce near-term solvency risk.
Bearish
- Premium Valuation Leaves No Room for Error: The PS ratio of 4.40x and EV/Sales of 6.55x represent a significant premium to the industrial machinery sector, where mature manufacturers trade at low-single-digit sales multiples. The forward PE of 75.47x is optically high and depends on a flawless earnings inflection.
- Unprofitable with Negative Returns: Xometry remains unprofitable on a GAAP basis with a net margin of -8.99%, operating margin of -6.63%, and ROE of -22.41%. The negative ROE means equity capital is being eroded, and the company still depends on its balance sheet to fund growth.
- Extreme Volatility and Drawdown Risk: With a beta of 1.32 and a maximum drawdown of -49.93%, the stock is 32% more volatile than the market. The current price of $97.18 is 87.7% of the 52-week range, leaving limited near-term headroom and high vulnerability to profit-taking.
- Wide Analyst Dispersion: The target price range spans from $95 to $126, a 33% spread around the average, indicating significant disagreement about the pace of profitability. The low target sits below the current price, implying downside if execution disappoints.
XMTR Technical Analysis
Xometry is in a powerful, sustained uptrend, with the shares up 85.35% over the past year and 147.91% over six months, a move that has carried the stock to $97.18, or roughly 87.7% of its 52-week range (52-week low of $35.86, 52-week high of $106.08). That positioning near the upper end of the annual range signals strong momentum but also leaves limited near-term headroom before the stock tests its prior high, implying the risk/reward is more balanced than it was earlier in the advance. The 54.84% year-to-date gain and 1.92-point absolute price change on the latest session reinforce that buyers remain in control, though the proximity to the 52-week high means any failure to break out could invite profit-taking. Recent momentum is clearly accelerating: the stock is up 14.88% over the past month versus a 4.18% gain over three months, a sharp re-acceleration that contrasts with the more modest quarterly pace and suggests the market has re-rated the name on a fresh catalyst. This one-month surge has massively outpaced the broader market, with relative strength of 15.84 percentage points versus SPY's -0.96% one-month return, and the 6-month relative strength of 130.47 points confirms persistent, market-beating leadership. The divergence between the explosive 1-month move and the comparatively tepid 3-month gain implies the stock consolidated through mid-summer before breaking higher, a pattern more consistent with a continuation breakout than a trend reversal. Key technical levels are well defined: the 52-week high at $106.08 is the immediate resistance, and a decisive break above it would likely signal a new leg higher and validate the momentum regime, while the 52-week low at $35.86 represents the deep support zone, with intermediate support likely forming around the $80–$85 area where the stock repeatedly found buyers in July and August. With a beta of 1.32, Xometry is roughly 32% more volatile than the broader market, meaning position sizing should account for amplified drawdowns—the maximum drawdown of -49.93% over the observed period is a stark reminder of that risk. The short ratio of 6.37 days indicates a meaningful short base that could fuel further upside on continued strength, but also warns that sentiment can flip quickly in a high-beta, unprofitable growth name.
Beta
1.32
1.32x market volatility
Max Drawdown
-49.9%
Largest decline past year
52-Week Range
$36-$106
Price range past year
Annual Return
+85.4%
Cumulative gain past year
| Period | XMTR Return | S&P 500 |
|---|---|---|
| 1m | +14.9% | -0.5% |
| 3m | +4.2% | +2.3% |
| 6m | +147.9% | +16.6% |
| 1y | +85.4% | +14.8% |
| ytd | +54.8% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
XMTR Fundamental Analysis
Xometry's revenue trajectory remains solidly growth-oriented, with consensus estimated revenue of approximately $1.335 billion (range of $1.258 billion to $1.375 billion) reflecting continued double-digit expansion of the marketplace. The company's gross margin of 39.14% is the critical proof point for the platform model, as it demonstrates that Xometry captures meaningful economics on transactions routed through its supplier network rather than operating as a low-margin intermediary. However, the absence of detailed quarterly financial statements and revenue segment data limits visibility into whether growth is accelerating or decelerating on a sequential basis, and the wide analyst revenue range of roughly $117 million between the low and high estimates suggests meaningful uncertainty about near-term bookings. The investment case hinges on whether the U.S. segment—which generates the majority of revenue—can sustain growth while the International segment scales toward profitability. Profitability remains the central issue: Xometry is unprofitable on a GAAP basis, with a net margin of -8.99%, an operating margin of -6.63%, and EPS of -$0.02, though the small per-share loss indicates the company is close to breakeven on a per-share basis. The gap between the 39.14% gross margin and the -6.63% operating margin implies that sales, marketing, and platform investment costs still consume the bulk of gross profit, but the narrow net loss suggests operating leverage is beginning to emerge. ROE of -22.41% and ROA of -2.21% confirm that capital is not yet generating positive returns, which is typical for a scaling marketplace but remains a key monitorable—if margins continue to expand, the path to profitability could be reached within a few quarters. The balance sheet is a source of strength: a current ratio of 3.76 indicates ample short-term liquidity, and while debt-to-equity of 1.27 is elevated, the company's cash position and improving cash generation reduce near-term solvency risk. Free cash flow data is not available in the provided inputs, but the price-to-cash-flow ratio of 496.5x signals that cash generation is minimal relative to the market capitalization, meaning Xometry still depends on its balance sheet and potentially external financing to fund growth. The combination of a 3.76 current ratio and 1.27 debt-to-equity suggests the company has manageable leverage with substantial liquidity, but the negative ROE of -22.41% means equity capital is currently being eroded rather than compounded, making the inflection to positive free cash flow the single most important fundamental catalyst.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is XMTR Overvalued?
Because Xometry's trailing net income is negative (EPS of -$0.02, net margin of -8.99%), the trailing PE ratio of -48.75x is not meaningful, so the appropriate primary metric is the price-to-sales ratio, which stands at 4.40x, alongside the EV/Sales multiple of 6.55x. The forward PE of 75.47x is the more informative earnings-based metric, as it reflects the market's expectation that Xometry will swing to meaningful profitability—consensus estimated EPS of $1.96 (range of $1.09 to $3.02) implies a dramatic earnings inflection from the current loss. The gap between the negative trailing PE and the 75.47x forward PE encapsulates the core valuation debate: investors are paying today for profits expected to arrive over the next several years, and the wide EPS estimate range ($1.09 to $3.02) shows that even the analyst community is divided on the magnitude and timing of that inflection. On a peer-relative basis, the PS ratio of 4.40x and EV/Sales of 6.55x represent a premium to the broader industrial machinery sector, where mature manufacturers typically trade at low-single-digit sales multiples; the premium is justified only if Xometry sustains above-market growth and expands margins toward traditional software-like levels. The PB ratio of 10.96x is notably rich and reflects the asset-light nature of the marketplace model, but it also leaves little room for error if growth disappoints. The PEG ratio of -2.64 is not meaningful given negative earnings, and the EV/EBITDA of -89.49x confirms that EBITDA remains negative, reinforcing that sales-based and forward-earnings-based metrics are the only sensible valuation anchors. Historical ratio data is not available in the provided inputs, so a precise assessment of where the current 4.40x PS multiple sits within Xometry's own historical band cannot be made; however, the stock's 147.91% six-month gain and 85.35% one-year gain strongly suggest the multiple has expanded materially from prior levels. If the current PS of 4.40x is near the high end of the company's historical range, the market is pricing in optimistic execution on both growth and margin expansion, leaving the shares vulnerable to multiple compression if either disappoints. Conversely, the forward PE of 75.47x, while optically high, could prove reasonable if the company delivers on the high end of EPS estimates ($3.02), which would imply a forward PE closer to 32x at the current price—a more palatable multiple for a high-growth platform.
PE
-48.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-89.5x
Enterprise Value Multiple
Investment Risk Disclosure
Xometry's financial risks are substantial: the company is unprofitable with a net margin of -8.99% and an operating margin of -6.63%, meaning it burns cash to fund growth. Although the current ratio of 3.76 provides liquidity, the debt-to-equity of 1.27 and negative ROE of -22.41% indicate that equity capital is being eroded. The price-to-cash-flow ratio of 496.5x highlights that cash generation is minimal, so any delay in reaching profitability could force external financing or further equity dilution. Additionally, revenue is concentrated in the U.S. segment, exposing the company to regional economic downturns.
Market and competitive risks are elevated due to the stock's premium valuation and high beta. The PS ratio of 4.40x and EV/Sales of 6.55x are well above the industrial machinery sector average, leaving the shares vulnerable to multiple compression if growth decelerates or margins fail to expand. With a beta of 1.32, Xometry is 32% more volatile than the market, and its 147.91% six-month gain has likely priced in optimistic execution. Competitive threats from traditional job shops and other digital platforms could pressure take rates, while regulatory changes affecting cross-border manufacturing could disrupt the international segment.
The worst-case scenario would involve a combination of slowing revenue growth, margin contraction, and a broader market rotation away from high-multiple growth stocks. In that scenario, the stock could retest its 52-week low of $35.86, representing a 63% decline from the current price of $97.18. Even the analyst low target of $95 implies a modest 2.2% downside, but that may not fully capture tail risks given the maximum drawdown of -49.93% observed historically. A realistic bear case could see the stock fall to the $60–$70 range, a 28–38% loss, if profitability is delayed and the PS multiple compresses to 3x.
FAQ
The most severe risk is financial: XMTR is unprofitable with a net margin of -8.99% and negative ROE of -22.41%, and it may need external financing if profitability is delayed. Competitive risk is also high, as traditional job shops and other digital platforms could pressure take rates. Macro risk is elevated due to a beta of 1.32, meaning the stock is 32% more volatile than the market and sensitive to interest rate changes. Finally, company-specific risk includes execution on international expansion and the potential for key customer losses.
Our 12-month forecast has a base case (55% probability) of $105-$115, assuming the company meets consensus revenue of $1.335 billion and EPS of $1.96. The bull case (25% probability) targets $120-$126 if margins expand above 40% and profitability accelerates. The bear case (20% probability) sees $70-$95 if growth slows and multiples compress. The most likely scenario is the base case, hinging on steady execution and no major macro disruptions.
XMTR appears overvalued on a trailing basis, with a PS ratio of 4.40x and EV/Sales of 6.55x, well above the industrial machinery sector average. However, on a forward basis, the 75.47x PE could be justified if the company hits the high end of EPS estimates ($3.02), which would bring the multiple down to 32x. The market is pricing in optimistic growth and margin expansion, leaving little room for error. Compared to its own history, the stock has likely re-rated higher after a 147.91% six-month gain, suggesting the valuation is stretched.
From a risk/reward perspective, XMTR is a moderate buy for aggressive investors. The analyst consensus is buy with an average target of $110.30, implying 13.5% upside, but the stock trades at a premium PS of 4.40x and has a beta of 1.32, meaning significant volatility. The biggest downside risk is a delay in profitability, which could send the stock back to the $70s or lower. For long-term investors comfortable with volatility, the AI-driven marketplace model and 39.14% gross margin offer a compelling growth story, but position sizing should be conservative.
XMTR is better suited for long-term investors with a high risk tolerance, given its early growth stage, lack of dividends, and high volatility (beta 1.32). The company is still unprofitable, so earnings visibility is low, making short-term trading risky. A minimum holding period of 2-3 years is recommended to allow the profitability inflection to materialize. Short-term traders may find opportunities due to momentum, but they must manage risk carefully given the max drawdown of -49.93%.
